Baltimore - November 7, 2019 - Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the release of its QX ONE Droplet Digital PCR System to early access customers at the Association for Molecular Pathology (AMP) Meeting & Expo in Baltimore, November 7-11.

The QX ONE System automates each step of the ddPCR workflow, which includes droplet generation, amplification, and droplet reading.

The system can detect four colors simultaneously for 8-plex CNV detection, 5-plex mutation detection, and 4-plex gene expression detection.

"By fully integrating our market-leading ddPCR workflow, the QX ONE gives users sample-to-analysis results in a high-precision platform," said Lisa Jensen-Long, Vice President of Marketing for Bio-Rad's Digital Biology Group.

The QX ONE System is compatible with current ddPCR Supermixes, Assays, and Kits, and joins Bio-Rad's family of Droplet Digital PCR products that includes the QXDx ddPCR System, the first FDA-cleared digital PCR platform for clinical use.

During AMP, on November 6, Bio-Rad hosted three workshops highlighting the latest advancements in ddPCR technology:

The text above is a summary, you can read full article here.